Beranda › Skizofrenia
Uji klinis Skizofrenia yang merekrut di AS
105 studi untuk Skizofrenia merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Atlanta, GA22 studi
- Chicago, IL20 studi
- Little Rock, AR19 studi
- Hollywood, FL15 studi
- Boston, MA14 studi
- New York City, NY13 studi
- Houston, TX13 studi
- Hialeah, FL13 studi
- San Diego, CA13 studi
- Austin, TX13 studi
- Garden Grove, CA12 studi
- Germantown, MD11 studi
- Miami, FL10 studi
- Camden, NJ10 studi
- Richardson, TX9 studi
- Grand Prairie, TX8 studi
- Cambridge, MA8 studi
- Philadelphia, PA8 studi
- Dallas, TX8 studi
- Inglewood, CA8 studi
- El Cajon, CA8 studi
- Johns Creek, GA8 studi
- Los Angeles, CA8 studi
- Anaheim, CA8 studi
- Cincinnati, OH8 studi
- St. Louis, MO7 studi
- Springdale, AR7 studi
- Staten Island, NY7 studi
- Orange, CA7 studi
- Las Vegas, NV7 studi
- Pittsburgh, PA7 studi
- West Palm Beach, FL7 studi
- Torrance, CA6 studi
- New Haven, CT6 studi
- Orlando, FL6 studi
- Queens, NY6 studi
- Riverside, CA6 studi
- Akron, OH6 studi
- Nashville, TN6 studi
- The Bronx, NY6 studi
Berdasarkan negara bagian
- Alabama5 studi
- Arizona4 studi
- Arkansas21 studi
- California44 studi
- Colorado3 studi
- Connecticut9 studi
- Florida26 studi
- Georgia29 studi
- Illinois25 studi
- Maryland17 studi
- Massachusetts22 studi
- Michigan5 studi
- Minnesota4 studi
- Mississippi3 studi
- Missouri10 studi
- Nebraska6 studi
- Nevada7 studi
- New Jersey13 studi
- New York23 studi
- North Carolina4 studi
- Ohio18 studi
- Oklahoma4 studi
- Pennsylvania15 studi
- Tennessee6 studi
- Texas34 studi
- Virginia6 studi
- Washington8 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
iTBS to Enhance Social Cognition in People With Psychosis
Menerima peserta
Usia 18 hingga 39 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06118268Overnight Thalamic TES-TI to Modulate Sleep Spindles in Individuals With Schizophrenia Spectrum Disorders and Matched Healthy Controls
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 50 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07680114Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
Menerima pesertaFase 4
Usia 12 hingga 17 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT05648591Volatility in Paranoia (VIP) Trial: An RCT of Changes in Volatility With Psychotherapy
Menerima peserta
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06835556Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07101094A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
Menerima pesertaFase 1
Usia 18 hingga 55 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07615426Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
Menerima pesertaFase 3
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07686263NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
Menerima pesertaFase 3
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07114874Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
Menerima pesertaFase 3
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07227818NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
Menerima pesertaFase 3
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07105098Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
Menerima pesertaFase 3
Usia 5 hingga 17 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06229210Study to Evaluate the Safety and Efficacy of Ublituximab in Participants With Schizophrenia
Menerima pesertaFase 2
Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07680946A Study of Brenipatide in Adult Participants With Schizophrenia
Menerima pesertaFase 2
Usia 18 hingga 55 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07410507A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
Menerima pesertaFase 3
Usia 5 hingga 17 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07424404State Representation in Early Psychosis 2
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 15 hingga 45 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07834203A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
Menerima pesertaFase 4
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT07105111A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
Menerima pesertaFase 1
Usia 18 hingga 55 · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT07734493Circuitry-Guided Smoking Cessation in Schizophrenia (UH3)
Menerima peserta
Usia 22 hingga 65 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT05276050A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
Menerima pesertaFase 2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT0714591852-week Open Label Safety-Tolerability Study
Menerima pesertaFase 3
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07369154A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
Menerima pesertaFase 3
Usia 13 hingga 17 · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07288567Genetic Basis of the Risk and Consequences of Cannabis Exposure in Humans
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 21 hingga 60 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT06058702A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT
Menerima pesertaFase 1
Usia 18 hingga 55 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07061288A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
Menerima pesertaFase 2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT07459647Activities to Change Your Mood: A Test of the Acceptability and Initial Efficacy in Clinical Samples and Healthy Controls
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 31 Agu 2026 · NCT06911723Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.